Description of the Webinar
Autosomal dominant polycystic kidney disease (ADPKD) is the fourth leading cause of ESRD world wide and affects approximately 3,000,000 individuals globally. ADPKD is characterized by cyst growth and development leading to renal enlargement that continues unabated for decades prior to loss of kidney function. Imaging biomarkers using magnetic resonance techniques have been tested and developed that provide accurate, reproducible and reliable estimates of cyst burden and cyst growth over a relatively short period of time allowing for the evaluation of a variety of therapeutic agents.
This webinar webcast is also available for download at the bottom of this page.
About the Facilitator
Dr. Arlene Chapman - Chief, Section of Nephrology, Professor of Medicine University of Chicago School of Medicine.
Arlene Chapman is an international expert in autosomal dominant polycystic kidney disease (ADPKD). Dr. Chapman received her MD from McMaster University. She completed her internal medicine residency and nephrology fellowship training at Georgetown University School of Medicine, and her clinical research fellowship training at the University of Colorado School of Medicine. She was previously a member of the faculty at the University of Colorado and Emory University before joining the University of Chicago as Section Chief in March 2015.l